Novartis Ag (NVS) FCF Payout Ratio (2009 - 2025)
Novartis Ag (NVS) posted FCF Payout Ratio of 0.36 for Q2 2025, up 64.13% sequentially from 0.99 in Q4 2024, and up 24.53% YoY from 0.29 in Q2 2024.
Novartis Ag (NVS) FCF Payout Ratio (2009 - 2025) Analysis & Trends
Novartis Ag (NVS) has 9 years of FCF Payout Ratio data on file, last reported at 0.36 in Q2 2025.
- Quarterly FCF Payout Ratio rose 24.53% year-over-year to 0.36 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 1.3 (up 33.7% YoY) and the FY2025 annual result came in at 0.44, down 5.28% from the prior year.
- FCF Payout Ratio grew to 0.36 in Q2 2025 per NVS's latest filing, from 0.99 in the prior quarter.
- The five-year high for FCF Payout Ratio was 0.36 in Q2 2025, with the low at 1.31 in Q4 2022.
- Average FCF Payout Ratio over 5 years is 0.88, with a median of 1.02 recorded in 2023.
- Year-over-year, FCF Payout Ratio decreased 19.93% in 2022 and increased 24.53% in 2025.
- Novartis Ag's FCF Payout Ratio stood at 1.1 in 2021, then declined by 19.93% to 1.31 in 2022, then advanced by 20.46% to 1.05 in 2023, then gained by 5.28% to 0.99 in 2024, then soared by 64.13% to 0.36 in 2025.
- Business Quant data shows NVS's FCF Payout Ratio at 0.36 in Q2 2025, 0.99 in Q4 2024, and 0.47 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.51 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 2.14 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.87 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -6.01 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.72 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.92 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.43 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 1.12 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -0.36 |
| Dec 31, 2024 | -0.99 |
| Jun 30, 2024 | -0.47 |
| Dec 31, 2023 | -1.05 |
| Dec 31, 2022 | -1.31 |
| Dec 31, 2021 | -1.10 |
| Dec 31, 2020 | -1.00 |
| Jun 30, 2013 | 0.01 |
| Dec 31, 2012 | -0.37 |
| Jun 30, 2012 | -0.03 |
| Sep 30, 2011 | -0.02 |
| Mar 31, 2010 | -1.24 |
| Dec 31, 2009 | 2.09 |
| Jun 30, 2009 | 0.00 |
| Mar 31, 2009 | -1.69 |